Caribou Biosciences Inc (CRBU) — Financial Flexibility Index
Caribou Biosciences Inc (CRBU) has a Financial Flexibility Index of -0.51x as of June 2026. Free cash flow of $-22.79 Million (operating CF $-22.79 Million minus capex $1.00K) represents -1% of total liabilities ($44.67 Million). Check cash flow reinvestment rate of Caribou Biosciences Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Caribou Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Caribou Biosciences Inc across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Caribou Biosciences Inc.
Annual Financial Flexibility Index for Caribou Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Caribou Biosciences Inc. Explore debt repayment capacity of Caribou Biosciences Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.06x | $-109.63 Million | $-110.99 Million | $53.19 Million | ▲ +5.5% |
| 2024 | -2.18x | $-131.69 Million | $-138.20 Million | $60.36 Million | ▼ -70.4% |
| 2023 | -1.28x | $-81.68 Million | $-93.29 Million | $63.81 Million | ▼ -11.2% |
| 2022 | -1.15x | $-83.91 Million | $-90.97 Million | $72.89 Million | ▼ -113.5% |
| 2021 | -0.54x | $-29.40 Million | $-32.52 Million | $54.53 Million | ▼ -0.5% |
| 2020 | -0.54x | $-31.90 Million | $-33.22 Million | $59.48 Million | ▲ +6.1% |
| 2019 | -0.57x | $-31.12 Million | $-32.01 Million | $54.47 Million | — |